Nu Holdings heads into its August 6 earnings report with options traders more defensive than they've been in months, even as the stock rallies and analysts turn more constructive.
The clearest signal this week is in the options market. The put/call ratio climbed to 0.57 — more than two standard deviations above its 20-day average of 0.50, the highest defensive tilt in roughly six weeks. That's a meaningful shift for a name that spent most of June with a PCR comfortably below 0.50. The stock itself has continued higher, up nearly 3% on the week to $14.39 and 13% over the past month, so the hedging activity reads less like panic and more like disciplined protection ahead of a known catalyst.
The lending market offers no corroboration for the bearish options read. Borrow availability is extraordinarily loose — over 2,000% relative to shares already borrowed, meaning there are roughly twenty shares available for every one currently lent out. That's well above the 52-week floor of around 1,700%. Cost to borrow has drifted lower over the past month to just 0.38%, one of the cheapest levels in the recent history. Short interest itself is a modest 4.1% of free float, roughly flat on the month despite a small weekly uptick. The lending data tells a story of minimal squeeze risk and no meaningful short-side conviction — the positioning here is cautious rather than aggressive.
Analyst sentiment has swung sharply in recent weeks and the divergence within the Street is worth unpacking. JP Morgan raised its target to $20 on July 7 while maintaining Overweight — a bullish signal from a bellwether, arriving after a cluster of downgrades in May and June. Citigroup cut to Neutral in mid-June, B of A Securities moved all the way to Underperform with a $10 target, and Susquehanna also downgraded around the same time. The mean price target across the coverage universe is $17.93, implying around 25% upside from current levels — but that average masks a wide spread between the $10 bear case and the $20 bull case. The factor score on analyst recommendation divergence ranks in the 92nd percentile, confirming this is one of the more contested names in the sector right now. EPS momentum scores are strong — 84th percentile on a 30-day basis and 87th on 90-day — suggesting the fundamental trajectory is holding even as sentiment splits.
Insider activity has been consistently one-directional. CEO David Velez, co-founder Cristina Junqueira, and the CFO all sold shares in April at prices around $14.44 — almost exactly where the stock trades today. Junqueira sold a combined $4.4 million in late March. These are not distress sales by any measure, and the values involved are modest relative to total holdings, but the pattern of founder-level selling near current prices is worth noting as the stock approaches a significant earnings event.
The last two earnings prints produced a -4.9% day-one reaction in May and a sharper -8.9% move after the February release. In both cases the stock recovered over the following week — May's print erased the loss within five sessions. Brazilian fintech peer ITUB4 fell 2.5% on the week while BMA and BBAS3 posted modest gains, suggesting no broad sector headwind specific to this reporting period. What makes August 6 particularly interesting is the tension between improving fundamentals, a stock that has already re-rated 13% higher this month, and a Street that remains genuinely split on valuation — the next print will likely determine which camp is vindicated.
See the live data behind this article on ORTEX.
Open NU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
